Louden T L
Caring. 1985 Jan;4(1):21-5.
Proponents of high tech home care cite its significant cost savings compared to similar therapies provided in an inpatient setting. Further proof of its cost effectiveness may, indeed, provide support for more attractive reimbursement coverage in the future and greater use of such therapies. However, at the present time, existing and prospective providers should proceed cautiously given the potential reimbursement pitfalls and increased competition. Hospitals, in particular, are increasingly interested in participating in this market, either through providing all aspects of the program or only parts. As such, agencies may find them either to be competitors or affiliated partners in providing high tech home care. Agencies have a variety of choices to make regarding high tech home care: provide specialized nursing care, provide equipment/supplies, handle billing, or handle it all. Whatever the approach, it is critical to understand the reimbursement aspects and target marketing efforts to hospitals, high tech product companies. HMOs, and perhaps most important, physicians.
高科技家庭护理的支持者指出,与住院环境中提供的类似治疗相比,它能显著节省成本。其成本效益的进一步证明可能确实会为未来更具吸引力的报销覆盖范围以及更多地使用此类治疗提供支持。然而,目前,考虑到潜在的报销陷阱和竞争加剧,现有和未来的供应商应谨慎行事。特别是医院,越来越有兴趣通过提供项目的各个方面或仅部分方面来参与这个市场。因此,机构可能会发现它们在提供高科技家庭护理方面既是竞争对手,也是附属合作伙伴。机构在高科技家庭护理方面有多种选择:提供专业护理、提供设备/用品、处理计费或全部包揽。无论采用何种方法,了解报销方面并将营销目标对准医院、高科技产品公司、健康维护组织,也许最重要的是医生,这一点至关重要。